MARC Record from marc_columbia

LEADER: 03925cam a22005774a 4500
001 6094750
005 20221121234214.0
008 060523t20062006enka b 001 0 eng
010 $a 2006017302
015 $aGBA662309$2bnb
016 7 $a101277429$2DNLM
016 7 $a013511751$2Uk
020 $a0470029242 (hardback : alk. paper)
020 $a9780470029244 (hardback : alk. paper)
020 $a0470029250 (pbk. : alk. paper)
020 $a9780470029251 (pbk. : alk. paper)
024 3 $a9780470029244
024 3 $a9780470029251
029 1 $aNLM$b101277429
029 1 $aYDXCP$b100431014
029 1 $aYDXCP$b100431018
035 $a(OCoLC)ocm69671918
035 $a(OCoLC)69671918
035 $a(NNC)6094750
035 $a6094750
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dUKM$dBTCTA$dC#P$dYDXCP$dYDX
042 $apcc
050 00 $aRM302.5$b.T49 2006
060 10 $aQZ 42$bT3556 2006
082 00 $a615/.7042$222
245 00 $aTextbook of pharmacoepidemiology /$ceditors, Brian L. Strom and Stephen E. Kimmel.
260 $aChichester, West Sussex, England ;$aHoboken, NJ :$bJohn Wiley & Sons,$c[2006], ©2006.
300 $axiv, 498 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $a"This textbook is the abridged version of Pharmacoepidemiology fourth edition"--P. [4] of cover.
504 $aIncludes bibliographical references and index.
505 0 $aWhat is pharmacoepidemiology? -- Study designs available for pharmacoepidemiology studies -- Sample size considerations for pharmacoepidemiology studies -- Basic principles of clinical pharmacology relevant to pharmacoepidemiology studies -- When should one perform pharmacoepidemiology studies? -- Views from academia, industry, and regulatory agencies -- Spontaneous reporting in the United States -- Global drug surveillance : the WHO Programme for International Drug Monitoring -- Case-control surveillance -- Prescription-event monitoring -- Overview of automated databases in pharmacoepidemiology -- Examples of automated databases -- Other approaches to pharmacoepidemiology studies -- How should one perform pharmacoepidemiology studies? choosing among the available alternatives -- Validity of pharmacoepidemiologic drug and diagnosis data --
505 0 $aBias and confounding in pharmacoepidemiology -- Determining causation from case reports -- Molecular pharmacoepidemiology -- Bioethical issues in pharmacoepidemiologic research -- The use of randomized controlled trials for pharmacoepidemiology studies -- The use of pharmacoepidemiology to study beneficial drug effects -- Pharmacoeconomics : economic evaluation of pharmaceuticals -- Using quality-of-life measurements in pharmacoepidemiologic research -- The use of meta-analysis in pharmacoepidemiology -- Patient adherence to prescribed drug dosing regimens in ambulatory pharmacotherapy -- Novel approaches to pharmacoepidemiology study design and statistical analysis -- Special applications of pharmacoepidemiology -- The future of pharmacoepidemiolgy.
650 0 $aPharmacoepidemiology$vTextbooks.
650 12 $aPharmacoepidemiology$xmethods.$0https://id.nlm.nih.gov/mesh/D017891Q000379
650 22 $aDrug Evaluation.$0https://id.nlm.nih.gov/mesh/D004341
650 22 $aDrug Monitoring.$0https://id.nlm.nih.gov/mesh/D016903
650 22 $aDrug Therapy.$0https://id.nlm.nih.gov/mesh/D004358
650 22 $aTreatment Outcome.$0https://id.nlm.nih.gov/mesh/D016896
650 0 $aPharmacoepidemiology.$0http://id.loc.gov/authorities/subjects/sh89004031
700 1 $aStrom, Brian L.$0http://id.loc.gov/authorities/names/n88088423
700 1 $aKimmel, Stephen E.$0http://id.loc.gov/authorities/names/n2006182085
730 0 $aPharmacoepidemiology.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0614/2006017302.html
852 00 $boff,hsl$hRM302.5$i.T49 2006